Grifols (GIKLY) Free Cash Flow (2010 - 2019)
Grifols (GIKLY) posted Free Cash Flow of $116.3 million for Q1 2020, down 69.02% quarter-over-quarter from $375.5 million in Q4 2019, and up 161.02% year-on-year from $44.6 million in Q2 2019.
Grifols (GIKLY) Free Cash Flow (2010 - 2019) Analysis & Trends
Grifols (GIKLY) has reported Free Cash Flow for 10 consecutive years, with $116.3 million the latest figure, recorded in Q1 2020.
- Free Cash Flow for Q1 2020 came in at $116.3 million, up 161.02% year-over-year; the trailing twelve-month figure through Dec 2021 was $116.3 million (down 76.35% YoY), and the FY2025 annual result was $910.3 million, up 60.73% from the prior year.
- Free Cash Flow was $116.3 million for Q1 2020 at Grifols, down from $375.5 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $671.8 million in Q4 2017 and troughed at -$190.6 million in Q1 2019.
- Average Free Cash Flow over 5 years is $234.2 million, with a median of $194.8 million recorded in 2016.
- Year-over-year, Free Cash Flow surged 244.9% in 2017 and slumped 267.38% in 2019.
- Over 5 years, Free Cash Flow stood at $194.8 million in 2016, then soared by 244.9% to $671.8 million in 2017, then tumbled by 30.55% to $466.5 million in 2018, then declined by 19.52% to $375.5 million in 2019, then slumped by 69.02% to $116.3 million in 2020.
- Per Business Quant data, the three most recent Free Cash Flow figures were $116.3 million in Q1 2020, $375.5 million in Q4 2019, and -$190.6 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 3.01 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 1.47 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.56 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 547.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.93 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.48 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 2.43 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.18 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | 346.00 Mn |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 375.47 Mn |
| Dec 31, 2019 | 375.47 Mn |
| Dec 31, 2018 | 466.54 Mn |
| Dec 31, 2018 | 466.54 Mn |
| Dec 31, 2017 | 671.81 Mn |
| Dec 31, 2017 | 671.81 Mn |
| Dec 31, 2016 | 194.78 Mn |
| Dec 31, 2016 | 194.78 Mn |
| Dec 31, 2015 | 340.22 Mn |
| Dec 31, 2015 | 340.22 Mn |
| Dec 31, 2014 | -818.53 Mn |
| Dec 31, 2014 | -818.53 Mn |
| Dec 31, 2013 | 308.02 Mn |
| Dec 31, 2013 | 308.02 Mn |
| Sep 30, 2013 | 113.22 Mn |
| Sep 30, 2013 | 113.22 Mn |
| Jun 30, 2013 | 245.33 Mn |
| Jun 30, 2013 | 245.33 Mn |
| Mar 31, 2013 | 121.97 Mn |
| Mar 31, 2013 | 121.97 Mn |